| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |